Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HAP2
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016311 | dephosphorylation | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0016791 | phosphatase activity | 5 | 2 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 184 | 186 | PF00675 | 0.391 |
CLV_NRD_NRD_1 | 228 | 230 | PF00675 | 0.405 |
CLV_PCSK_KEX2_1 | 228 | 230 | PF00082 | 0.405 |
CLV_PCSK_SKI1_1 | 260 | 264 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.296 |
DEG_APCC_DBOX_1 | 259 | 267 | PF00400 | 0.438 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.641 |
DOC_CDC14_PxL_1 | 177 | 185 | PF14671 | 0.228 |
DOC_CDC14_PxL_1 | 263 | 271 | PF14671 | 0.326 |
DOC_CKS1_1 | 201 | 206 | PF01111 | 0.345 |
DOC_CYCLIN_yCln2_LP_2 | 39 | 45 | PF00134 | 0.517 |
DOC_MAPK_gen_1 | 185 | 193 | PF00069 | 0.371 |
DOC_MAPK_gen_1 | 255 | 265 | PF00069 | 0.430 |
DOC_MAPK_gen_1 | 47 | 56 | PF00069 | 0.286 |
DOC_MAPK_MEF2A_6 | 20 | 27 | PF00069 | 0.445 |
DOC_MAPK_MEF2A_6 | 310 | 318 | PF00069 | 0.545 |
DOC_MAPK_MEF2A_6 | 47 | 56 | PF00069 | 0.247 |
DOC_MAPK_NFAT4_5 | 49 | 57 | PF00069 | 0.275 |
DOC_PP1_RVXF_1 | 328 | 334 | PF00149 | 0.631 |
DOC_PP2B_LxvP_1 | 37 | 40 | PF13499 | 0.416 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.421 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.485 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.147 |
DOC_USP7_MATH_1 | 353 | 357 | PF00917 | 0.610 |
DOC_USP7_UBL2_3 | 148 | 152 | PF12436 | 0.304 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.311 |
DOC_WW_Pin1_4 | 321 | 326 | PF00397 | 0.496 |
LIG_14-3-3_CanoR_1 | 138 | 144 | PF00244 | 0.405 |
LIG_14-3-3_CanoR_1 | 167 | 172 | PF00244 | 0.252 |
LIG_14-3-3_CanoR_1 | 185 | 193 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 2 | 7 | PF00244 | 0.579 |
LIG_14-3-3_CanoR_1 | 228 | 235 | PF00244 | 0.490 |
LIG_EVH1_1 | 37 | 41 | PF00568 | 0.447 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.326 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.435 |
LIG_FHA_1 | 300 | 306 | PF00498 | 0.271 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.235 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.319 |
LIG_GBD_Chelix_1 | 52 | 60 | PF00786 | 0.236 |
LIG_LIR_Apic_2 | 32 | 38 | PF02991 | 0.479 |
LIG_LIR_Gen_1 | 139 | 147 | PF02991 | 0.304 |
LIG_LIR_Gen_1 | 89 | 98 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 139 | 144 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 286 | 291 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 89 | 94 | PF02991 | 0.264 |
LIG_PDZ_Class_1 | 354 | 359 | PF00595 | 0.543 |
LIG_Pex14_2 | 109 | 113 | PF04695 | 0.405 |
LIG_Pex14_2 | 31 | 35 | PF04695 | 0.487 |
LIG_PTB_Apo_2 | 332 | 339 | PF02174 | 0.457 |
LIG_SH2_PTP2 | 143 | 146 | PF00017 | 0.208 |
LIG_SH2_PTP2 | 91 | 94 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 143 | 146 | PF00017 | 0.424 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.229 |
LIG_SH3_1 | 198 | 204 | PF00018 | 0.236 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.236 |
LIG_SH3_3 | 30 | 36 | PF00018 | 0.354 |
LIG_SH3_3 | 313 | 319 | PF00018 | 0.450 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.356 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.147 |
LIG_SH3_5 | 86 | 90 | PF00018 | 0.317 |
LIG_SUMO_SIM_par_1 | 188 | 195 | PF11976 | 0.231 |
LIG_SUMO_SIM_par_1 | 50 | 55 | PF11976 | 0.228 |
LIG_SxIP_EBH_1 | 319 | 330 | PF03271 | 0.548 |
LIG_TRAF2_1 | 230 | 233 | PF00917 | 0.322 |
LIG_TRFH_1 | 200 | 204 | PF08558 | 0.228 |
LIG_TYR_ITIM | 88 | 93 | PF00017 | 0.304 |
LIG_WW_2 | 41 | 44 | PF00397 | 0.550 |
MOD_CDK_SPK_2 | 200 | 205 | PF00069 | 0.322 |
MOD_CK1_1 | 139 | 145 | PF00069 | 0.396 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.405 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.396 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.374 |
MOD_Cter_Amidation | 183 | 186 | PF01082 | 0.405 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.654 |
MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.462 |
MOD_GlcNHglycan | 340 | 343 | PF01048 | 0.459 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.288 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.187 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.311 |
MOD_GSK3_1 | 329 | 336 | PF00069 | 0.493 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.275 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.275 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.464 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.318 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.177 |
MOD_NEK2_1 | 299 | 304 | PF00069 | 0.402 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.412 |
MOD_NEK2_1 | 333 | 338 | PF00069 | 0.540 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.309 |
MOD_NEK2_2 | 344 | 349 | PF00069 | 0.438 |
MOD_PIKK_1 | 165 | 171 | PF00454 | 0.254 |
MOD_PIKK_1 | 227 | 233 | PF00454 | 0.345 |
MOD_PK_1 | 186 | 192 | PF00069 | 0.304 |
MOD_PKA_1 | 185 | 191 | PF00069 | 0.405 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.450 |
MOD_PKA_2 | 227 | 233 | PF00069 | 0.439 |
MOD_Plk_1 | 215 | 221 | PF00069 | 0.345 |
MOD_Plk_1 | 344 | 350 | PF00069 | 0.562 |
MOD_Plk_1 | 56 | 62 | PF00069 | 0.228 |
MOD_Plk_4 | 139 | 145 | PF00069 | 0.327 |
MOD_Plk_4 | 186 | 192 | PF00069 | 0.287 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.559 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.260 |
MOD_Plk_4 | 329 | 335 | PF00069 | 0.400 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.228 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.228 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.311 |
MOD_ProDKin_1 | 321 | 327 | PF00069 | 0.487 |
TRG_ENDOCYTIC_2 | 141 | 144 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.263 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.369 |
TRG_ER_diArg_1 | 227 | 229 | PF00400 | 0.405 |
TRG_NES_CRM1_1 | 135 | 149 | PF08389 | 0.304 |
TRG_Pf-PMV_PEXEL_1 | 260 | 264 | PF00026 | 0.443 |
TRG_PTS1 | 356 | 359 | PF00515 | 0.543 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D2 | Leptomonas seymouri | 73% | 100% |
A0A0S4IR87 | Bodo saltans | 26% | 80% |
A0A0S4IXS3 | Bodo saltans | 32% | 93% |
A0A0S4J698 | Bodo saltans | 33% | 77% |
A0A0S4J952 | Bodo saltans | 36% | 100% |
A0A0S4JFL1 | Bodo saltans | 34% | 100% |
A0A0S4JJI6 | Bodo saltans | 39% | 96% |
A0A0S4JU68 | Bodo saltans | 35% | 100% |
A0A1X0NUJ8 | Trypanosomatidae | 51% | 99% |
A0A3S7X7S3 | Leishmania donovani | 87% | 100% |
A0A422N4T2 | Trypanosoma rangeli | 51% | 100% |
A4I9T8 | Leishmania infantum | 87% | 100% |
C9ZXU7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
C9ZXU8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9B4U9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q377 | Leishmania major | 86% | 100% |
Q8JIL9 | Xenopus laevis | 30% | 100% |
V5B4L5 | Trypanosoma cruzi | 52% | 100% |